Olema (NASDAQ: OLMA) awards director 29,500 stock options
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Olema Pharmaceuticals director Gorjan Hrustanovic received a grant of stock options for 29,500 shares of common stock at an exercise price of $9.51 per share. The options expire on June 18, 2036 and vest in 12 equal monthly installments starting June 18, 2026, with any remaining unvested portion vesting in full on the date of Olema’s next annual stockholder meeting if not already fully vested, subject to his continued service. Under a pre-existing arrangement, any economic benefit from the sale of shares issued upon exercise is payable to BVF Partners L.P., and Hrustanovic disclaims beneficial ownership except for any pecuniary interest.
Positive
- None.
Negative
- None.
Insider Trade Summary
1 transaction reported
Mixed
1 txn
Insider
Hrustanovic Gorjan
Role
null
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (right to buy) | 29,500 | $0.00 | -- |
Holdings After Transaction:
Stock Option (right to buy) — 29,500 shares (Direct, null)
Footnotes (1)
- The shares subject to the option vest in a series of 12 successive equal monthly installments measured from June 18, 2026, subject to the Reporting Person's continuous service through each applicable vesting date. Such shares vest in full on the date of the Issuer's next annual meeting of stockholders if such stock option is not otherwise fully vested by such date, subject to the Reporting Person's continuous service through such vesting date. The Reporting Person is a member of BVF Partners L.P. ("BVF") and is obligated to transfer the economic benefit, if any, received upon the sale of the shares issuable upon exercise of the equity grants to BVF. As such, the Reporting Person disclaims beneficial ownership of the securities reported herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, except to the extent of his pecuniary interest therein, if any.
Key Figures
Option grant size: 29,500 options
Exercise price: $9.51 per share
Expiration date: June 18, 2036
+3 more
6 metrics
Option grant size
29,500 options
Stock Option (right to buy) granted to director
Exercise price
$9.51 per share
Strike price for Olema common stock under options
Expiration date
June 18, 2036
Option term end for the grant
Vesting schedule
12 equal monthly installments
Measured from June 18, 2026, subject to continuous service
Alternative vesting trigger
Full vesting by next annual meeting
If not fully vested earlier and with continued service
Shares underlying options
29,500 shares
Olema common stock issuable upon exercise
Key Terms
Stock Option (right to buy), beneficial ownership, pecuniary interest, Section 16 of the Securities Exchange Act of 1934, +1 more
5 terms
Stock Option (right to buy) financial
"security_title: Stock Option (right to buy)"
beneficial ownership regulatory
"the Reporting Person disclaims beneficial ownership of the securities reported herein"
Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.
pecuniary interest financial
"except to the extent of his pecuniary interest therein, if any"
Section 16 of the Securities Exchange Act of 1934 regulatory
"for purposes of Section 16 of the Securities Exchange Act of 1934, as amended"
A provision of federal securities law that requires company insiders—directors, officers and large shareholders—to publicly report their stock holdings and trades and to surrender any “short-swing” profits from purchases and sales within a six-month window. It acts like a rule that forces leaders to announce their trades and prevents quick buy-sell windfalls, giving investors transparency into insider activity and reducing opportunities for unfair gain.
continuous service financial
"subject to the Reporting Person's continuous service through each applicable vesting date"
FAQ
What did Olema Pharmaceuticals (OLMA) director Gorjan Hrustanovic receive in this Form 4 filing?
He received a grant of stock options for 29,500 shares of Olema common stock at a $9.51 exercise price. These options are a compensation award, not an open-market stock purchase or sale, and provide potential future ownership if exercised.
What are the key terms of Gorjan Hrustanovic’s Olema (OLMA) stock option grant?
The grant covers 29,500 options to buy Olema common stock at $9.51 per share, expiring June 18, 2036. The options vest over time, giving him the right, but not the obligation, to purchase shares at this fixed price if exercised.
How do the Olema (OLMA) stock options granted to Gorjan Hrustanovic vest over time?
The options vest in 12 equal monthly installments starting June 18, 2026, conditioned on continued service. Any remaining unvested options vest in full on the date of Olema’s next annual stockholder meeting if they are not already fully vested by that time.
Who ultimately benefits economically from Gorjan Hrustanovic’s Olema (OLMA) option grant?
Hrustanovic is obligated to transfer any economic benefit from selling shares issued on exercise to BVF Partners L.P. He therefore disclaims beneficial ownership of these securities, except to the extent of any pecuniary interest he may have through this arrangement.